1. Home
  2. GSIW vs TRAW Comparison

GSIW vs TRAW Comparison

Compare GSIW & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIW
  • TRAW
  • Stock Information
  • Founded
  • GSIW 2016
  • TRAW 1998
  • Country
  • GSIW Hong Kong
  • TRAW United States
  • Employees
  • GSIW N/A
  • TRAW N/A
  • Industry
  • GSIW
  • TRAW
  • Sector
  • GSIW
  • TRAW
  • Exchange
  • GSIW Nasdaq
  • TRAW NYSE
  • Market Cap
  • GSIW 8.3M
  • TRAW 7.8M
  • IPO Year
  • GSIW 2023
  • TRAW 2013
  • Fundamental
  • Price
  • GSIW $1.15
  • TRAW $1.65
  • Analyst Decision
  • GSIW
  • TRAW
  • Analyst Count
  • GSIW 0
  • TRAW 0
  • Target Price
  • GSIW N/A
  • TRAW N/A
  • AVG Volume (30 Days)
  • GSIW 2.1M
  • TRAW 3.5M
  • Earning Date
  • GSIW 12-31-2024
  • TRAW 05-15-2025
  • Dividend Yield
  • GSIW N/A
  • TRAW N/A
  • EPS Growth
  • GSIW N/A
  • TRAW N/A
  • EPS
  • GSIW N/A
  • TRAW N/A
  • Revenue
  • GSIW $1,313,795.00
  • TRAW $227,000.00
  • Revenue This Year
  • GSIW N/A
  • TRAW $3.81
  • Revenue Next Year
  • GSIW N/A
  • TRAW $30.43
  • P/E Ratio
  • GSIW N/A
  • TRAW N/A
  • Revenue Growth
  • GSIW N/A
  • TRAW 0.44
  • 52 Week Low
  • GSIW $0.35
  • TRAW $0.97
  • 52 Week High
  • GSIW $12.30
  • TRAW $19.44
  • Technical
  • Relative Strength Index (RSI)
  • GSIW 78.55
  • TRAW 54.15
  • Support Level
  • GSIW $0.73
  • TRAW $1.30
  • Resistance Level
  • GSIW $0.77
  • TRAW $2.58
  • Average True Range (ATR)
  • GSIW 0.10
  • TRAW 0.23
  • MACD
  • GSIW 0.03
  • TRAW 0.07
  • Stochastic Oscillator
  • GSIW 86.84
  • TRAW 34.04

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About TRAW TRAWS PHARMA INC

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.

Share on Social Networks: